Recent Quarter Total Invested
$7.35 B
Recent Quarter Institutional Ownership Percentage
132.84%
Total Invested of Last Quarter
$8.18 B
Ownership Percentage of Last Quarter
114.45%
Cytokinetics, Incorporated Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK INC. | 08/13/2024 | 14.67 M | $794.97 M | 18.19% | 14.40% |
| FMR LLC | 08/13/2024 | 11.52 M | $624.32 M | 5.71% | 11.31% |
| VANGUARD GROUP INC | 08/13/2024 | 11.44 M | $619.69 M | 14.41% | 11.22% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 8.14 M | $440.95 M | 58.91% | 7.99% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 7.51 M | $406.87 M | 88.61% | 7.37% |
| STATE STREET CORP | 08/14/2024 | 6.55 M | $354.80 M | 44.87% | 6.42% |
| DARWIN GLOBAL MANAGEMENT, LTD. | 08/14/2024 | 4.58 M | $246.07 M | 100.00% | 4.49% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 4.38 M | $237.35 M | -8.31% | 4.30% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 2.74 M | $148.41 M | 21.87% | 2.69% |
| RTW INVESTMENTS, LP | 08/14/2024 | 2.72 M | $147.43 M | 7.77% | 2.67% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2024 | 2.45 M | $132.99 M | 52.88% | 2.41% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 2.36 M | $127.78 M | -19.54% | 2.31% |
| BOXER CAPITAL, LLC | 08/14/2024 | 2.10 M | $113.78 M | 0.00% | 2.06% |
| VESTAL POINT CAPITAL, LP | 08/14/2024 | 2.08 M | $112.42 M | -3.49% | 2.04% |
| ARMISTICE CAPITAL, LLC | 08/14/2024 | 2.07 M | $111.94 M | 35.41% | 2.03% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 1.88 M | $101.81 M | 6.16% | 1.84% |
| PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 1.77 M | $95.80 M | 0.83% | 1.73% |
| PFM HEALTH SCIENCES, LP | 08/14/2024 | 1.76 M | $95.20 M | 0.00% | 1.72% |
| MARSHALL WACE, LLP | 08/14/2024 | 1.68 M | $90.92 M | -34.36% | 1.65% |
| MELQART ASSET MANAGEMENT (UK) LTD | 08/14/2024 | 1.68 M | $90.79 M | 70.41% | 1.64% |
| NORTHERN TRUST CORP | 08/14/2024 | 1.28 M | $69.51 M | 15.43% | 1.26% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 1.14 M | $61.67 M | 64.60% | 1.12% |
| PENTWATER CAPITAL MANAGEMENT LP | 07/31/2024 | 1.12 M | $60.63 M | 3.61% | 1.10% |
| JPMORGAN CHASE & CO | 08/12/2024 | 1.11 M | $60.25 M | 61.60% | 1.09% |
| SARISSA CAPITAL MANAGEMENT LP | 08/14/2024 | 1.11 M | $60.14 M | 270.00% | 1.09% |
| MORGAN STANLEY | 10/17/2024 | 1.11 M | $59.91 M | 15.79% | 1.08% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 1.07 M | $57.90 M | 18.73% | 1.05% |
| ARMISTICE CAPITAL, LLC | 08/14/2024 | 1.00 M | $54.18 M | 42.86% | 0.98% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 08/14/2024 | 1.00 M | $54.18 M | 122.22% | 0.98% |
| RP MANAGEMENT, LLC | 08/13/2024 | 980,392 | $53.12 M | 100.00% | 0.96% |
| JANUS HENDERSON GROUP PLC | 08/14/2024 | 976,329 | $52.89 M | 22.44% | 0.96% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 925,682 | $50.15 M | 19.36% | 0.91% |
| PENTWATER CAPITAL MANAGEMENT LP | 07/31/2024 | 920,900 | $49.89 M | 0.00% | 0.90% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 08/14/2024 | 873,513 | $47.33 M | 19.43% | 0.86% |
| CITADEL ADVISORS LLC | 08/14/2024 | 858,973 | $46.54 M | 53.14% | 0.84% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 853,862 | $46.26 M | 167.24% | 0.84% |
| ORBIMED ADVISORS LLC | 08/14/2024 | 812,906 | $44.04 M | 19.07% | 0.80% |
| NORGES BANK | 08/14/2024 | 799,664 | $43.33 M | 100.00% | 0.78% |
| BROWN ADVISORY INC | 08/14/2024 | 762,549 | $41.31 M | 0.40% | 0.75% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 08/14/2024 | 737,637 | $39.97 M | 5.88% | 0.72% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 601,367 | $32.58 M | -10.92% | 0.59% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 555,110 | $30.08 M | -26.99% | 0.54% |
| FISHER ASSET MANAGEMENT, LLC | 08/14/2024 | 534,520 | $28.96 M | -0.79% | 0.52% |
| INVESCO LTD. | 08/13/2024 | 495,398 | $26.84 M | -62.40% | 0.49% |
| ARTAL GROUP S.A. | 08/14/2024 | 494,421 | $26.79 M | -2.40% | 0.49% |
| GREAT POINT PARTNERS LLC | 08/14/2024 | 474,202 | $25.69 M | 134.52% | 0.47% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 470,967 | $25.52 M | 28.69% | 0.46% |
| ENSIGN PEAK ADVISORS, INC | 08/13/2024 | 463,431 | $25.11 M | 9.23% | 0.45% |
| FRANKLIN RESOURCES INC | 08/14/2024 | 403,561 | $21.86 M | -28.61% | 0.40% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2024 | 398,100 | $21.57 M | 0.00% | 0.39% |
Cytokinetics, Incorporatedinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CYTK shares?
During the previous two years, 407 institutional investors and hedge funds held shares of Cytokinetics, Incorporated. The most heavily invested institutionals were:
VALLEY NATIONAL ADVISERS INC: 0
Lynx Investment Advisory: 0
Chemistry Wealth Management LLC: 0
nVerses Capital, LLC: 0
BlackRock Inc.: 14.67 M
FMR LLC: 11.52 M
-
What percentage of Cytokinetics, Incorporated stock is owned by institutional investors?
132.84% of Cytokinetics, Incorporated stock is owned by institutional investors.
-
How much institutional buying is happening at CYTK ?
Institutional investors have bought a total of 143.48 M shares in the last 24 months. This purchase volume represents approximately $7.42 B in transactions.